The Dividend Screener Says High Yield. But These Chemical Stocks Tell a Different Story

Trailing yield takes the last 12 months of dividends and divides them by today’s share price. When a company cuts partway through the year, that window still holds the old, larger checks, so a screener reads high while the rate actually being paid is much lower. That distortion is live across the chemical sector right now. All but one of the seven major U.S.-listed chemical names below have already reduced their quarterly payouts, and LyondellBasell (NYSE:LYB | LYB Price Prediction) still shows a dividend yield of 7.09% on one widely used data feed.

A quick way to judge any payout: it holds up when earnings and free cash flow (operating cash flow minus capital spending) cover it without new debt. With a recently cut dividend, first confirm the yield you see is based on the current declared rate.

LyondellBasell: A Trailing Yield Built on a Rate It No Longer Pays

LyondellBasell paid $1.37 per share each quarter before its reduction. Its first ex-dividend date at the new $0.69 rate was March 2, 2026. The trailing 12-month total still reads $3.44 because it combines both rates, while the annualized forward rate is $2.76. Those numbers disagree, and the forward figure is the one a shareholder gets from here if the current rate holds. Shares sit at $57.92, up 38.2% year to date.

Coverage is uneven. Trailing diluted EPS is -$0.83, so GAAP earnings do not cover the payout. In the June quarter, operating cash flow of $752 million topped capital spending of $270 million and dividends of $224 million. In the March quarter, operating cash flow was negative $269 million against the same $224 million dividend bill.

The risk is that the strong quarter came from geopolitics. Management tied it to Middle East supply disruption, and CFO Agustin Izquierdo said on the July call that “investment grade continues to be paramount,” with the near-term priority to “rebuild the balance sheet.” The bull case: CEO Peter Vanacker said normalization will be “measured in quarters, not months,” which could stretch the margin boost.

FMC: A Wider Gap That Has Drawn Less Attention

FMC (NYSE:FMC) paid $0.58 a quarter before cutting to $0.08, with the first ex-dividend date at the lower rate on December 31, 2025. The trailing 12-month total is $0.82; the annualized forward rate is $0.32. That mismatch produces a screener yield of 8.56% with the stock trading at $9.30. The price drop feeds the fantasy: shares are down 71.39% over the past year.

Coverage looks stretched even at the lower rate. Trailing diluted EPS is -$21.49, and the second quarter produced a GAAP net loss of $186.6 million, including $222.3 million of restructuring. Full-year adjusted EPS guidance now stands at $1.19 to $1.49. Free cash flow guidance of $75 million to $225 million includes a one-time $200 million licensing payment from Corteva.

The risk here is leverage. Net debt ran 5.1 times trailing EBITDA at quarter-end, and deleveraging leans on asset sales plus an equity investment from Tessenderlo that has since closed. The bull case rests on management’s outlook of a return to growth in 2027.

(red flags that a big yield is about to be cut, exactly the checklist we put in a free dividend trap report: here.)

Celanese, Chemours, Huntsman and Dow Show How Broad the Reset Ran

Celanese (NYSE:CE), Chemours (NYSE:CC), Huntsman (NYSE:HUN) and Dow (NYSE:DOW) round out a sector-wide correction completed inside roughly two years.

• Celanese made the most severe reduction of the group. Its common dividend spending went from $307 million in 2024 to $13 million in 2025, and net debt stands at $10.64 billion.
• Chemours has negative stockholders’ equity of -$49 million and net leverage of 4.4x.
• Huntsman still shows a trailing dividend of $0.513 per share and a screener yield of 5.76%, while second-quarter free cash flow was negative $90 million.
• Dow offers the bull case: second-quarter free cash flow of $692 million against $253 million in dividends.

Olin: A Payout That Never Falls and Never Rises

Olin (NYSE:OLN) has never cut. It paid $0.20 per share at its May 6, 1999 ex-dividend date and pays $0.20 today. For a reader at or near retirement, a payout frozen that long loses purchasing power every year prices rise, and that erosion never shows as a cut on any screener.

Its 4.92% screener yield reflects shares down 30.32% over the past year. Net leverage runs 5.0x adjusted EBITDA, and about $100 million in legacy Shintech litigation payments are expected in the second half of 2026. The combined OlinHuntsman has not announced a dividend policy.

Check the Declared Quarterly Rate First

A dividend cut usually drags the stock down with it, and in this sector the cuts already happened. Before acting on any chemical yield, check the most recent declared quarterly amount and the forward rate it implies, and ignore the trailing figure. Yield alone shouldn’t drive your buy decision. For company-level balance sheet work, see our chemical sector dividend safety deep dive.

Contact [email protected] for any questions or corrections.